HOME >> BIOLOGY >> NEWS
MRI drug may improve cancer-killing ability of chemotherapy, study says

A contrast agent currently used in magnetic resonance imaging (MRI), called mangafodipir, may increase the cancer-killing ability of some chemotherapy drugs while protecting normal cells, according to a study in the February 15 issue of the Journal of the National Cancer Institute .

Many anticancer drugs work by increasing the levels of tumor cell hydrogen peroxide. Tumor cells are particularly sensitive to hydrogen peroxide and die as a result. However, certain enzymes in the body can work to protect cells from this kind of damage, rendering certain cancer drugs less effective. In addition, the drugs are toxic to normal cells. The drug mangafodipir, a contrast agent given to patients before they have an MRI, helps promote the production of hydrogen peroxide while at the same time, through different biologic mechanisms, protects healthy cells from the negative effects of oxidative damage.

Jrme Alexandre, M.D., of the Groupe hospitalier Cochin-Saint Vincent de Paul in Paris, and colleagues exposed tumor cells and white blood cells from 10 cancer patients and white blood cells from six control subjects to three chemotherapy drugs--paclitaxel, oxaliplatin, and 5-fluorouracil--in the presence or absence of mangafodipir. They also studied the effects of mangafodipir on colon cancer cells in mice treated with paclitaxel.

The authors found that mangafodipir protected the white blood cells taken from healthy volunteers and from cancer patients. The drug also protected paclitaxel-treated mice from infection that would cause a lowered white blood cell count and helped increase the cancer cell-killing ability of the chemotherapy drug paclitaxel against the cancer cells in mice.

"Our results support investigation of the use of mangafodipir in cancer patients, because mangafodipir may enhance the therapeutic index of anticancer agents by both protecting normal cells and increasing antitumoral activity of these agents," the authors wri
'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
14-Feb-2006


Page: 1 2

Related biology news :

1. New test improves detection of liver cancer
2. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
3. Gene expression pattern could lead to improved treatment of pediatric septic shock
4. Additional mammogram readers improve breast cancer detection
5. New role for protein in fat cells may improve understanding of obesity and diabetes
6. Jefferson scientists patent dramatically improves
7. Cardiac patches stimulate regeneration, improve function after heart attack
8. Co-operation between GSF and clinic improves outlook for sarcoma patients
9. EPA foregoes opportunity to improve nanotechnology oversight
10. Biocontrol of invasive water hyacinth contributes to socioeconomic and health improvements in Africa
11. Kansas, Missouri School Board members to explore improvements in science-related education

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 20, 2020 , ... Catalent, the ... biologics, cell and gene therapies, and consumer health products, today announced that Jean-François ... presenting at the ISCT 2020 Paris Virtual conference, which takes place on 28 ...
(Date:5/15/2020)... FREDERICK, Md. (PRWEB) , ... May 15, 2020 , ... ... a boutique intellectual property law firm based in Frederick, Maryland and Tysons Corner, Virginia, ... the field of biotechnology and a another in the field of chemistry. The firm ...
(Date:5/14/2020)... ... May 14, 2020 , ... The ... sales representatives, found the 2019 average medical sales rep total compensation increased by ... by uncertainties amid the COVID-19 global crisis. , The MedReps 2020 Salary Survey ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... Pa. (PRWEB) , ... April 06, 2020 , ... ... and process solutions for the life sciences industry, has announced the release of ... developing quickly, our top priority is the health and safety of our employees ...
(Date:4/1/2020)... Texas (PRWEB) , ... March 30, 2020 , ... ... (APMD) and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to ... COVID-19 pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an ...
(Date:4/1/2020)... ... March 31, 2020 , ... Carterra® Inc., the world leader in high-throughput ... that they will use Carterra’s proprietary LSA™ platform to screen hundreds of antibodies in ... early as this summer. , La Jolla Institute for Immunology (LJI) has ...
(Date:3/27/2020)... Kansas (PRWEB) , ... March ... ... proudly announces the opening of its veterinary histopathology laboratory located centrally in ... partnering clients the ability to work with a highly motivated, independent, professional ...
Breaking Biology Technology:
Cached News: